KAUST and Janssen Pharmaceutical (Johnson & Johnson) are collaborating to research and innovate in neglected tropical diseases, focusing on dengue fever. They signed an MoU to establish a dengue fever research program and an infectious disease R&D center at KAUST's National BioPark. The partnership marks Johnson & Johnson's first university collaboration in Saudi Arabia. Why it matters: This collaboration signifies a major step in localizing disease research within Saudi Arabia and leveraging KAUST's AI, genomics, and data simulation expertise to address global health challenges.
MBZUAI hosted delegates from the US-UAE Business Council Trade Mission to discuss research and education partnerships. Discussions focused on AI research and collaboration in healthcare, with representatives from Abbott, Johnson & Johnson, and leading children's hospitals participating. Potential personnel exchanges and R&D facility development were also explored during the meeting. Why it matters: This engagement strengthens ties between US and UAE institutions, potentially accelerating AI innovation in healthcare and other sectors.
KAUST and the International Medical Center (IMC) have signed an MoU to collaborate on medical research related to wellness, quality of life, and population health management. The partnership aims to develop AI applications for diagnosis and treatment, along with research in precision medicine and advanced therapies. The collaboration aligns with Saudi Vision 2030's goals to build a sustainable, knowledge-driven healthcare future. Why it matters: This agreement signifies a push to integrate AI and precision medicine into practical medical solutions within the Saudi healthcare system.
The Research Products Development Company (RPDC) signed an agreement with The Saudi Vaccine and Biomanufacturing Center (SVBC) to establish a research and industrial center in Saudi Arabia for vaccine and biopharmaceutical development. Supported by KACST and hosted by KAUST, the SVBC will provide a state-of-the-art facility and a training platform. Cooperation agreements were also signed with GE for equipment supply and with Fujifilm Dayosent Biotechnology for MERS-CoV treatment development. Why it matters: This initiative aims to localize vaccine and advanced treatment industries in Saudi Arabia, create technical jobs, and reduce reliance on imports in line with Vision 2030.
KAUST Assistant Professor Dominik Michels received the first Procter & Gamble (P&G) Faculty Award for his research contributions to the consumer goods industry. Michels has a long-standing academic partnership with P&G, contributing to the development and integration of computer-aided product development techniques into P&G's workflow. The collaborative projects have focused on AI, machine learning, and scientific/visual computing. Why it matters: This award highlights KAUST's growing role in applied AI research and its successful partnerships with major global corporations, facilitating technology transfer and real-world impact.
KAUST and the SFDA co-hosted the "Trends in Microbiome and Digital One Health" conference from October 30 to November 1, 2023, featuring 35 speakers from five continents. Discussions centered on microbiome science, digital tools for tracking microbial epidemiology, and their roles in the One Health concept. The conference facilitated the formation of a consortium for microbiome and Digital One Health research. Why it matters: This event highlights Saudi Arabia's growing focus on leveraging microbiome research and digital technologies to address public health challenges and promote international collaboration in the field.
Lockheed Martin's CTO, Dr. Dana Jackson, spoke at KAUST about the company's collaborative R&D goals. He cited the Apollo 11 moon landing as a major inspiration for his career in science and technology. The lecture took place on the KAUST campus on October 22. Why it matters: Such talks can foster collaboration between industry leaders like Lockheed Martin and academic institutions like KAUST, potentially catalyzing innovation in Saudi Arabia.
Jean M. J. Fréchet, retired KAUST senior vice president, has been awarded the King Faisal Prize in Chemistry for his pioneering work in dendrimers, photoresists, and organic photovoltaics. His work has contributed to advancements in biotherapeutics, organic electronics, materials, and microfluidics. Fréchet is the 10th most cited chemist globally, with over 900 publications and 200 patents. Why it matters: The recognition highlights KAUST's impact on global scientific advancement and underscores the importance of investing in basic research with broad applications.